A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma

Clinical trial NCT06942442 · RECRUITING

Trial details

NCT number: NCT06942442
Sponsor: Sarcoma Alliance for Research through Collaboration
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

HLA-A*0201 Positive Cells Present Clear Cell Sarcoma (CCS)

Start date: 2025-10-22
Primary completion: 2030-10-01
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.